Pediatric oncology research
In the relentless battle against cancer, researchers and clinicians are continuously seeking innovative approaches to improve treatment outcomes and minimize side effects. Among the most promising developments in cancer therapy is the emergence of antibody-drug conjugates (ADCs), a class of targeted biopharmaceuticals designed to deliver potent cytotoxic agents directly to cancer cells while sparing healthy
